01 12Blake Cassels & Graydon LLP
02 4Janssen Inc.
03 2Smart & Biggar
04 2Smart & Biggar LLP
01 32135062
02 42175370
03 12194564
04 42352818
05 42406536
06 22687979
07 22800111
01 4RISPERIDONE
02 16Risperidone
01 3Orally Disintegrating Tablet
02 4POWDER FOR SUSPENSION, SUSTAINED-RELEASE
03 12Powder for Injectable Prolonged-Release Suspension
04 1Solution
01 21931-05-31
02 32013-05-03
03 42014-11-11
04 12015-07-04
05 42019-12-10
06 42021-04-19
07 22028-02-13
Patent Expiration Date : 2015-07-04
Date Granted : 1998-01-27
Brand Name : RISPERDAL
Patent Number : 2194564
Filing Date : 1995-07-04
Strength per Unit : 1 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-07-04
Date Granted : 1998-01-27
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Brand Name : RISPERDAL CONSTA
Patent Number : 2352818
Filing Date : 1999-12-10
Strength per Unit : 25 mg / vial
Dosage Form : Powder for Injectable Prolonged-Release Suspension
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Brand Name : RISPERDAL CONSTA
Patent Number : 2352818
Filing Date : 1999-12-10
Strength per Unit : 37.5 mg / vial
Dosage Form : Powder for Injectable Prolonged-Release Suspension
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Brand Name : RISPERDAL CONSTA
Patent Number : 2352818
Filing Date : 1999-12-10
Strength per Unit : 50 mg / vial
Dosage Form : Powder for Injectable Prolonged-Release Suspension
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Brand Name : RISPERDAL CONSTA
Patent Number : 2352818
Filing Date : 1999-12-10
Strength per Unit : 12.5 mg / vial
Dosage Form : Powder for Injectable Prolonged-Release Suspension
Human Or VET : Human
Route of Administration : Intramuscular injection
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Patent Expiration Date : 2013-05-03
Date Granted : 1999-05-25
Brand Name : RISPERDAL M-TAB
Patent Number : 2135062
Filing Date : 1993-05-03
Strength per Unit : 0.5 mg
Dosage Form : Orally Disintegrating Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-03
Date Granted : 1999-05-25
Patent Expiration Date : 2013-05-03
Date Granted : 1999-05-25
Brand Name : RISPERDAL M-TAB
Patent Number : 2135062
Filing Date : 1993-05-03
Strength per Unit : 1 mg
Dosage Form : Orally Disintegrating Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-03
Date Granted : 1999-05-25
Patent Expiration Date : 2013-05-03
Date Granted : 1999-05-25
Brand Name : RISPERDAL M-TAB
Patent Number : 2135062
Filing Date : 1993-05-03
Strength per Unit : 2 mg
Dosage Form : Orally Disintegrating Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-03
Date Granted : 1999-05-25
Patent Expiration Date : 2021-04-19
Date Granted : 2009-12-22
Brand Name : RISPERDAL CONSTA
Patent Number : 2406536
Filing Date : 2001-04-19
Strength per Unit : 25 mg / vial
Dosage Form : Powder for Injectable Prolonged-Release Suspension
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2021-04-19
Date Granted : 2009-12-22
Patent Expiration Date : 2014-11-11
Date Granted : 2006-06-26
Brand Name : RISPERDAL CONSTA
Patent Number : 2175370
Filing Date : 1994-11-11
Strength per Unit : 25 mg / vial
Dosage Form : Powder for Injectable Prolonged-Release Suspension
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2014-11-11
Date Granted : 2006-06-26
